CDC SBIR awards and R&D opportunities
CDC funds public health technology through SBIR. CDC's official SBIR site has its current topics and deadlines.
- Awards, 2022–2026
- 77
- Awarded
- $34.8 million
- Phase II share
- 19%
- Open CDC R&D notices
- 0
Open CDC R&D opportunities
No open CDC R&D notices on SAM.gov right now. CDC's SBIR topics are published on its own site; see open R&D notices from every agency.
Get alerts for R&D notices from CDC
FedReady emails you new BAAs, R&D solicitations and SBIR/STTR notices from SAM.gov in your research area, the week they post. Free.
Get R&D alertsCDC and the 2026 SBIR restart
SBIR and STTR lapsed from October 1, 2025 until the Small Business Innovation and Economic Security Act reauthorized them on April 13, 2026, through September 30, 2031. NIH issued new SBIR (PA-27-100) and STTR (PA-27-102) funding opportunities on May 28, 2026, with standard due dates of September 5, January 5 and April 5. HHS now limits each company to nine new Phase I, Fast-Track and Direct to Phase II applications per fiscal year.
CDC SBIR and STTR awards by year
| Award year | Phase I | Phase II | Dollars |
|---|---|---|---|
| 2025 | 3 | 3 | $3.5 million |
| 2024 | 13 | 6 | $11.9 million |
| 2023 | 20 | 2 | $8.3 million |
| 2022 | 26 | 4 | $11 million |
| 2021 | 15 | 3 | $7.3 million |
| 2020 | 14 | 11 | $13.7 million |
| 2019 | 24 | 5 | $8 million |
| 2018 | 35 | 4 | $10 million |
| 2017 | 12 | 7 | $9 million |
| 2016 | 21 | 6 | $9.3 million |
2025 and 2026 are low because the programs' authority lapsed from October 2025 to April 2026, and because agencies report new awards to SBIR.gov months late (some agencies' newest reported awards are from 2024 or 2025).
Top CDC SBIR recipients
Small businesses with the most CDC SBIR and STTR dollars since 2022:
| Company | State | Awards | Dollars |
|---|---|---|---|
| Vectech, Inc. | MD | 2 | $2.3 million |
| Empowerx, Inc. | CA | 2 | $2.2 million |
| Saavsus Inc | OR | 2 | $2.2 million |
| Mendon Group LLC | NY | 3 | $1.7 million |
| Nanohmics Inc | TX | 3 | $1.5 million |
| Creare LLC | NH | 3 | $1.5 million |
| Oregon Research Behavioral Intervention Strategies, Inc. | OR | 3 | $1.5 million |
| Herowear LLC | TN | 1 | $1.5 million |
| Iasis Molecular Sciences Inc. | WA | 1 | $1.3 million |
| Charles River Analytics, Inc. | MA | 2 | $1.2 million |
| Seacoast Science, Inc. | CA | 3 | $1.1 million |
| Cell Podium LLC | NJ | 1 | $1 million |
| Lo Biosciences, Inc. | MD | 1 | $994,658 |
| Luna Labs USA LLC | VA | 1 | $899,997 |
| Minnesota Healthsolutions Corporation | MN | 2 | $700,375 |
Newest CDC SBIR and STTR awards
| Awarded | Company | Project | Amount |
|---|---|---|---|
| Sep 30, 2025 | Seacoast Science, Inc. | SBIR Phase II Auto-calibrating, Air Quality Monitoring System | $541,648 |
| Sep 30, 2025 | Nanohmics Inc | SBIR Phase II Lateral Flow-Electrochemiluminescent (LF-ECL) Test Strips and Portable Reader for Ultrasensitive Foodborne… | $1 million |
| Sep 30, 2025 | SKM Instruments, LLC | SBIR Phase I Ultra-Rapid Optical Platform for Antimicrobial Susceptibility Testing (AST) ofPulmonary Non-Tuberculous… | $306,872 |
| Sep 30, 2025 | Chromologic LLC | SBIR Phase I Wearable Heat Related Injury Risk Analysis (WHERA) system Resubmission | $306,469 |
| Sep 30, 2025 | Lo Biosciences, Inc | SBIR Phase II A novel remote blood separation device for at-home plasma collection for HIV-1 testing | $994,658 |
| Sep 30, 2025 | Hawai'i Innovation Inc. | SBIR Phase I METAVEST: Advanced Biomimetic Personal Cooling for Enhancing Heat Safety Among High-Risk Workers | $302,424 |
| Sep 30, 2024 | Empowerx, Inc. | SBIR Phase II Hormonal contraceptive Access via Pharmacist-Prescribing Implementation package (HAPPI) | $1.9 million |
| Sep 30, 2024 | Kinima, Inc. | SBIR Phase I SBIR, Augmented Reality Personalized Motion Tracking, Assessment, and Improvement Technology for Fall… | $397,205 |
| Sep 30, 2024 | Tarawa Labs Inc | SBIR Phase I SBIR, Phase I, Preventing healthcare-acquired, antibiotic-resistant bacterial infections with single… | $312,559 |
| Sep 30, 2024 | Kephera Diagnostics LLC | SBIR Phase I MiCRIA: Two-minute rapid assay platform for point-of-care diagnosis | $303,250 |
| Sep 30, 2024 | Saavsus Inc | SBIR Phase II Development, Feasibility, and Acceptability of Aim to Play, a User-Friendly Digital Application for Teacher… | $1.9 million |
| Sep 1, 2024 | Innovative Design Labs Inc | SBIR Phase I Active Arm-Support Industrial Exoskeleton to Reduce Work-Related Musculoskeletal Disorders (WRMSDs) | $302,409 |
Frequently asked questions
How many SBIR awards does CDC make?
Centers for Disease Control and Prevention made 77 SBIR awards worth $34.8 million from 2022 through the latest SBIR.gov data, 15 of them Phase II. The average Phase I award was about $274,463 and average Phase II about $1.2 million.
Where does CDC post SBIR topics?
On its official SBIR/STTR site (www.cdc.gov/technology-and-innovation/php/small-business-innovation-research/index.html). Related R&D solicitations and broad agency announcements are also posted on SAM.gov.
Is CDC accepting SBIR proposals in 2026?
SBIR and STTR lapsed from October 1, 2025 until the Small Business Innovation and Economic Security Act reauthorized them on April 13, 2026, through September 30, 2031. NIH issued new SBIR (PA-27-100) and STTR (PA-27-102) funding opportunities on May 28, 2026, with standard due dates of September 5, January 5 and April 5. HHS now limits each company to nine new Phase I, Fast-Track and Direct to Phase II applications per fiscal year.
Other SBIR agencies
Award data from SBIR.gov's public award file, updated monthly; contact and researcher names are left out. Open notices from SAM.gov, updated daily.